GENERIC NAME OF THE MEDICINAL PRODUCT:
2. Diclofenac Potassium, Paracetamol and Serratiopeptidase Tablets (50mg+325mg+15mg)
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Each Film-coated tablet contains:
Diclofenac Potassium BP….50mg
Paracetamol IP…………………325mg
Serratiopeptidase IP…………10mg
(As enteric-coated granules)
(Eq. to 20,000 units of enzyme activity)
Excipients………………………….q.s
Colour: Sunset Yellow
2. Diclofenac Potassium, Paracetamol and Serratiopeptidase Tablets (50mg+325mg+15mg)
Each Film-coated tablet contains:
Diclofenac Potassium BP….50mg
Paracetamol IP…………………325mg
Serratiopeptidase IP…………15mg
(As enteric-coated granules)
(Eq. to 30,000 units of enzyme activity)
Excipients………………………….q.s
Colour: Sunset Yellow Lake
THERAPEUTIC INDICATIONS:
CAUTION & WARNING:
KEEP MEDICINE OUT OF REACH OF CHILDREN.
SWALLOW WHOLE DO NOT CHEW OR CRUSH.
WARNING: TAKING MORE THAN DAILY DOSE MAY CAUSE SERIOUS LIVER DAMAGE OR ALLERGIC REACTIONS (E.G., SWELLING OF THE FACE, MOUTH AND THROAT, DIFFICULTY IN BREATHING, ITCHING OR RASH).
WARNING : NOT TO BE SOLD BY RETAIL WITHOUT THE PRESCRIPTION OF A REGISTERED MEDICAL PRACTITIONER.
STORAGE & DOSAGE:
Protect from Light and moisture.
Dosage: As directed by the Physician.
Diclofenac Potassium, Paracetamol and Serratiopeptidase Tablets (50mg+325mg+10mg) Technical Specification:
| Product Name: | Diclofenac Potassium, Paracetamol and Serratiopeptidase Tablets |
| Brand Name: | Generic |
| Strength: | (50mg+325mg+10mg), (50mg+325mg+15mg) |
| Dosage Form: | Tablets(Film-coated) |
| Route of Administration: | Via Oral Route |
| Packing: | 10s, 30s, 100s, 500s |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet) |
| Documents: | COA, MOA, Stability Studies, GMP |
| Therapeutic use: | Analgesic and Anti-inflammatory, Anti-rheumatic |
| Indication: | The cogent combination of these tablets is used to relieve pain in conditions like joint pain, muscle pain, headache, dental pain, migraine, period pain, osteoarthritis, rheumatoid arthritis, and for some other pain-soothing purposes. |
| Storage: | Store below 30°C. Protect from Light and moisture. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
1. Diclofenac Potassium, Paracetamol and Serratiopeptidase Tablets (50mg+325mg+10mg)
2. Diclofenac Potassium, Paracetamol and Serratiopeptidase Tablets (50mg+325mg+15mg)
QUALITATIVE AND QUANTITATIVE COMPOSITION:
1. Diclofenac Potassium, Paracetamol and Serratiopeptidase Tablets (50mg+325mg+10mg)
Each Film-coated tablet contains:
Diclofenac Potassium BP….50mg
Paracetamol IP…………………325mg
Serratiopeptidase IP…………10mg
(As enteric-coated granules)
(Eq. to 20,000 units of enzyme activity)
Excipients………………………….q.s
Colour: Sunset Yellow
2. Diclofenac Potassium, Paracetamol and Serratiopeptidase Tablets (50mg+325mg+15mg)
Each Film-coated tablet contains:
Diclofenac Potassium BP….50mg
Paracetamol IP…………………325mg
Serratiopeptidase IP…………15mg
(As enteric-coated granules)
(Eq. to 30,000 units of enzyme activity)
Excipients………………………….q.s
Colour: Sunset Yellow Lake
THERAPEUTIC INDICATIONS:
The cogent combination of these tablets is used to relieve pain in conditions like joint pain, muscle pain, headache, dental pain, migraine, period pain, osteoarthritis, rheumatoid arthritis, and for some other pain-soothing purposes.
CAUTION & WARNING:
CAUTION: Read enclosed leaflet before use.
Keep medicine out of reach of children.
SWALLOW WHOLE DO NOT CHEW OR CRUSH.
WARNING: Taking more than daily dose may cause serious liver damage or allergic reactions (e.g., swelling of the face, mouth and throat, difficulty in breathing, itching or rash).
STORAGE & DOSAGE:
Storage: Store below 30°C.
Protect from Light and moisture.
Dosage: As directed by the Physician.
Introduction: Understanding Diclofenac Potassium, Paracetamol and Serratiopeptidase Tablets (50mg+325mg+10mg)
Diclofenac Potassium, Paracetamol and Serratiopeptidase Tablets (50mg+325mg+10mg) are a widely prescribed analgesic and anti-inflammatory formulation used for effective pain management. This fixed-dose combination brings together three potent agents—Diclofenac Potassium (50mg), Paracetamol (325mg), and Serratiopeptidase (10mg)—to deliver fast and long-lasting relief from pain, inflammation, and swelling.
Globally, the demand for this combination has surged due to its therapeutic efficacy in treating conditions such as:
-
Headache and migraine
-
Musculoskeletal pain
-
Dental pain
-
Osteoarthritis and rheumatoid arthritis
-
Post-operative inflammation
-
Sports injuries and trauma-related swelling
Taj Pharma, a leading WHO-GMP certified manufacturer in India, ensures consistent quality and efficacy of this triple-combination formulation. Each tablet is manufactured in compliance with international pharmacopoeia standards and global regulatory norms, making it suitable for export to multiple regulated and semi-regulated markets.
Mechanism of Action: How the Combination Works
This combination offers synergistic benefits through three pharmacological actions:
-
Diclofenac Potassium (50mg): A non-steroidal anti-inflammatory drug (NSAID) that blocks the synthesis of prostaglandins, thereby reducing pain and inflammation.
-
Paracetamol (325mg): An antipyretic and analgesic that lowers fever and enhances pain control.
-
Serratiopeptidase (10mg): A proteolytic enzyme that promotes healing by breaking down abnormal proteins at the inflammation site, reducing swelling, and improving tissue repair.
Together, these ingredients provide superior pain relief with faster onset of action and minimal gastrointestinal irritation compared to single-agent NSAIDs.
Global Demand and Market Growth
The global pain management pharmaceuticals market is valued at over USD 80 billion, with combination drugs accounting for a substantial share.
Countries in Asia, Africa, the Middle East, and Latin America have shown growing demand for high-quality generic formulations like Diclofenac Potassium, Paracetamol and Serratiopeptidase Tablets (50mg+325mg+10mg), especially from reliable Indian manufacturers such as Taj Pharma.
India’s pharmaceutical export strength, combined with WHO-GMP certification and stringent quality checks, has positioned Taj Pharma as a preferred exporter and supplier to healthcare organizations, hospitals, and distributors globally.
Regulatory Documentation and Export Readiness
For importers and global buyers, Taj Pharma provides a comprehensive regulatory dossier and documentation support, ensuring smooth registration and import approval processes.
Regulatory Support Includes:
-
WHO-GMP Certificate (World Health Organization Good Manufacturing Practices)
-
COPP (Certificate of Pharmaceutical Product)
-
CTD / ACTD Dossier (Common Technical Document format for registration)
-
Product Master File (PMF)
-
Free Sale Certificate
-
Stability Data and Method Validation
-
Batch Manufacturing Records (BMR) & Analytical Data
Custom Packaging and Labeling for International Buyers
Taj Pharma offers customized packaging and labeling options that comply with importing country regulations.
Export packs are available in blister, alu-alu, or strip packaging, with labels in English, French, Spanish, or Arabic, as per the buyer’s requirement.
Key Packaging Options:
-
10×10 tablets per box
-
Blister or Alu-Alu strips
-
Export-quality carton boxes
-
Tamper-proof and moisture-resistant packs
Shelf-Life, Storage, and Dosage Form
| Parameter | Specification |
|---|---|
| Dosage Form | Film-coated tablets |
| Strength | Diclofenac Potassium 50mg + Paracetamol 325mg + Serratiopeptidase 10mg |
| Shelf Life | 24 to 36 months |
| Storage | Store in a cool, dry place below 25°C, protected from moisture and sunlight |
| Appearance | White to off-white film-coated tablet |
| Pack Size | 10×10 or as per customer requirement |
Export Certifications and Compliance
Taj Pharma’s manufacturing facilities in Vapi, Gujarat (India) are certified and audited for compliance with international standards:
-
WHO-GMP Certified Plant
-
EU-GMP Standardized Production
-
ISO 9001:2015 Quality Management Certification
-
PIC/S and cGMP Guidelines Compliance
-
Regulatory Approvals across Africa, Southeast Asia, Latin America, and CIS countries
This strong regulatory foundation enables Taj Pharma to deliver globally accepted pharmaceutical products at competitive prices.
Why Taj Pharma is the Most Trusted Manufacturer, Supplier & Exporter
1. State-of-the-Art Manufacturing
Taj Pharma’s WHO-GMP certified facility in Vapi, Gujarat features advanced machinery, automated production lines, and strict quality control systems. Each batch of Diclofenac Potassium, Paracetamol and Serratiopeptidase Tablets undergoes rigorous testing in accordance with IP, BP, and USP standards.
2. Quality Assurance and Affordability
Quality and affordability go hand in hand at Taj Pharma. Their products are manufactured under validated processes, maintaining a perfect balance between cost efficiency and therapeutic performance.
3. Global Presence and Export Network
Taj Pharma exports to more than 40 countries including:
-
Vietnam, Cambodia, Philippines
-
Nigeria, Ghana, Kenya
-
Saudi Arabia, UAE, Yemen
-
Peru, Chile, Mexico
-
Ukraine, Russia, Uzbekistan
-
Sri Lanka, Nepal, Bangladesh
4. End-to-End Supply Chain Support
Taj Pharma provides door-to-port logistics, export documentation, and custom clearance support, ensuring timely delivery to international buyers.
Technical Product Specification Table
| Product Name | Diclofenac Potassium, Paracetamol and Serratiopeptidase Tablets |
|---|---|
| Strength | 50mg + 325mg + 10mg |
| Dosage Form | Film-coated tablets |
| Therapeutic Class | Analgesic, Anti-inflammatory |
| Pack Type | Blister / Alu-Alu strips |
| Packaging Size | 10×10 tablets / per box |
| Manufacturer | Taj Pharmaceuticals Ltd., Vapi, Gujarat, India |
| Certifications | WHO-GMP, ISO, COPP, CTD |
| Indications | Pain relief, inflammation, swelling, arthritis |
| Storage Condition | Below 25°C, dry and dark place |
| Shelf Life | 24–36 months |
| Export Markets | Asia, Africa, CIS, Latin America, Middle East |
PCD Pharma Franchise and PAN India Supply
Taj Pharma offers PAN India distribution and PCD Pharma franchise opportunities for Diclofenac Potassium, Paracetamol and Serratiopeptidase Tablets (50mg+325mg+10mg).
Partners benefit from marketing support, promotional materials, and a robust product portfolio in the pain management category.
Key Markets:
-
Mumbai, Maharashtra
-
Vapi, Gujarat
-
Delhi NCR
-
Hyderabad, Telangana
-
Chennai, Tamil Nadu
-
Kolkata, West Bengal
-
Lucknow, Uttar Pradesh
-
Ahmedabad, Gujarat
Taj Pharma ensures timely delivery and steady supply across domestic and international markets.
Why Global Buyers Trust Taj Pharma
-
100% WHO-GMP Certified Manufacturing Units
-
Internationally Compliant Documentation & Dossiers
-
Flexible MOQs & Competitive Pricing
-
Custom Branding & Private Label Exports
-
Strong Regulatory and Quality Assurance Team
-
Experience in Exporting to 40+ Countries
Taj Pharma’s expertise and dedication to global healthcare make it the #1 trusted supplier of Diclofenac Potassium, Paracetamol and Serratiopeptidase Tablets in India.
Call to Action
Looking for a reliable WHO-GMP certified manufacturer and supplier of Diclofenac Potassium, Paracetamol and Serratiopeptidase Tablets (50mg+325mg+10mg) in India?
📞 Contact Taj Pharma today to get the best export prices, documentation support, and partnership opportunities.
🌐 Visit: www.tajpharma.in
✉️ Email: info@tajpharma.com
🏭 Address: Taj Pharma Ltd., Vapi, Gujarat, India
Top 20 FAQs
1. What is the main use of Diclofenac Potassium, Paracetamol and Serratiopeptidase Tablets?
Used for pain relief and reducing inflammation in arthritis, dental pain, and musculoskeletal conditions.
2. Who manufactures these tablets in India?
Taj Pharma Ltd, a WHO-GMP certified manufacturer from Vapi, Gujarat, India.
3. Are these tablets suitable for export markets?
Yes, Taj Pharma exports to 40+ countries with COPP, WHO-GMP, and CTD dossiers.
4. What certifications are available?
WHO-GMP, ISO, COPP, and regulatory documentation per country requirements.
5. What are the side effects?
Nausea, dizziness, headache, mild stomach pain — usually self-resolving.
6. Can importers get customized packaging?
Yes, Taj Pharma offers multilingual, custom-designed export packaging.
7. What is the shelf life of the product?
Typically 24–36 months under recommended storage conditions.
8. What type of formulation is available?
Film-coated tablet form for oral administration.
9. Can Taj Pharma support dossier submission?
Yes, full CTD/ACTD dossiers and regulatory support are provided.
10. What dosage should be prescribed?
As directed by a healthcare professional; typically 1 tablet 2–3 times a day.
11. Is this medicine over-the-counter?
No, it should be taken under medical supervision.
12. Can it be used for post-surgical pain?
Yes, it effectively reduces swelling and pain post-surgery.
13. What are the export-friendly features of Taj Pharma’s tablets?
High-quality packaging, stability, and compliant documentation.
14. Do these tablets contain steroids?
No, they are non-steroidal anti-inflammatory agents.
15. Can the product be branded under buyer’s label?
Yes, Taj Pharma offers private labeling for international clients.
16. What makes Taj Pharma different from others?
Superior quality, regulatory compliance, and competitive pricing.
17. Are samples available for registration?
Yes, export samples can be arranged upon request.
18. Is there support for import registration?
Yes, Taj Pharma provides full technical and regulatory support.
19. What are the available pack sizes?
Standard 10×10 tablets per box, customizable as per buyer demand.
20. How can global distributors collaborate with Taj Pharma?
By reaching out through their website or email to initiate B2B discussions.






